×
Ultra-rapid detection of SARS-CoV-2 in public workspace environments.
https://doi.org/10.1371/journal.pone.0240524
PloS One; Yaren O, McCarter J et. al.

Feb 24th, 2021 - Managing the pandemic caused by SARS-CoV-2 requires new capabilities in testing, including the possibility of identifying, in minutes, infected individuals as they enter spaces where they must congregate in a functioning society, including workspaces, schools, points of entry, and commercial business establishments. Here, the only useful tests (a) require no sample transport, (b) require minima...

SARS-CoV-2 viral shedding characteristics and potential evidence for the priority for f...
https://doi.org/10.1371/journal.pone.0247367
PloS One; Yuan C, Wang H et. al.

Feb 22nd, 2021 - This study aimed to identify the specimen type that has high positivity and its proper sampling time for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) testing to promote diagnostic efficiency. All SARS-CoV-2-infected patients with a laboratory-confirmed diagnosis in Zhoushan City were followed up for viral shedding in respiratory tract specimens and faecal samples. Positivity was...

Feasibility and Predictive Performance of a Triage System for Patients with Cancer Duri...
https://doi.org/10.1002/onco.13706
The Oncologist; Fasola G, Pelizzari G et. al.

Feb 4th, 2021 - Triage procedures have been implemented to limit hospital access and minimize infection risk among patients with cancer during the coronavirus disease (COVID-19) outbreak. In the absence of prospective evidence, we aimed to evaluate the predictive performance of a triage system in the oncological setting. This retrospective cohort study analyzes hospital admissions to the oncology and hematolog...

SARS-CoV-2 infection in asymptomatic healthcare workers at a clinic in Chile.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7842995
PloS One; Olmos C, Campaña G et. al.

Jan 28th, 2021 - Asymptomatic SARS-CoV-2 infection of healthcare workers (HCWs) has been reported as a key player in the nosocomial spreading of COVID-19. Early detection of infected HCWs can prevent spreading of the virus in hospitals among HCWs and patients. We conducted a cross-sectional study to determine the asymptomatic infection of HCWs in a private clinic in the city of Santiago, Chile. Our study was co...

Clinical course and challenging management of early COVID-19 infection after heart tran...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7816134
BMC Infectious Diseases; Tchana-Sato V, Ancion A et. al.

Jan 21st, 2021 - There are limited data on Coronavirus disease 2019 (COVID-19) in solid organ transplant patients, especially in heart transplant recipients, with only a few case reports and case series described so far. Heart transplant recipients may be at particular high risk due to their comorbidities and immunosuppressed state. This report describes the clinical course and the challenging management of ear...

Detection-based prioritisation: Framework of multi-laboratory characteristics for asymp...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7647899
Artificial Intelligence in Medicine; Albahri AS, Hamid RA et. al.

Jan 19th, 2021 - Corona virus (COVID) has rapidly gained a foothold and caused a global pandemic. Particularists try their best to tackle this global crisis. New challenges outlined from various medical perspectives may require a novel design solution. Asymptomatic COVID-19 carriers show different health conditions and no symptoms; hence, a differentiation process is required to avert the risk of chronic virus ...

Parasites and Parasitology in this SARS-CoV-2, COVID-19 World: An American Society of P...
https://doi.org/10.1645/20-158
The Journal of Parasitology; Hillyer JF

Jan 15th, 2021 - The novel coronavirus disease 2019 (COVID-19) is one of the worst global health crises of this generation. The core of this pandemic is the rapid transmissibility of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus, its high morbidity and mortality, and the presence of infectious asymptomatic carriers. As a result, COVID-19 has dominated this year's headlines and commanded...

Challenge of post-COVID era: management of cardiovascular complications in asymptomatic...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7797272
Heart Failure Reviews; Gupta S, Mitra A

Jan 11th, 2021 - Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), a highly pathogenic member of family coronaviridae, has caused an exponentially growing global pandemic termed as the coronavirus disease 2019 (COVID-19) with more than 12 million cases worldwide till date. This deadly disease has average fatality rate of 6.5% and even higher among elderly patients and patients with comorbidities. SA...

Seroprevalence and asymptomatic carrier status of SARS-CoV-2 in Wuhan City and other pl...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7790301
PLoS Neglected Tropical Diseases; Duan S, Zhou M et. al.

Jan 7th, 2021 - Wuhan City (WH) in China was the first place to report COVID-19 in the world and the outbreak of COVID-19 was controlled in March of 2020 in WH. It is unclear what percentage of people were infected with SARS-CoV-2 and what percentage of population is carriers of SARS-CoV-2 in WH. We retrospectively analyzed the SARS-CoV-2 IgG and IgM antibody positive rates in 63,107 healthy individuals from W...

The role of serum specific- SARS-CoV-2 antibody in COVID-19 patients.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7759121
International Immunopharmacology; Chen H, Zhang X et. al.

Jan 5th, 2021 - Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), responsible for coronavirus disease 2019 (COVID-19), has rapidly spread, resulting in considerable casualties and serious economic loss worldwide. Disease severity and related symptoms markedly vary among individuals. A large number of patients present atypical symptoms, which represent a big challenge for early diagnosis and prompt ...

Informed sequential pooling approach to detect SARS-CoV-2 infection.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7773195
PloS One; Millioni R, Mortarino C

Dec 30th, 2020 - The alarming spread of the pandemic coronavirus disease 2019 (COVID-19) caused by the SARS-CoV-2 virus requires several measures to reduce the risk of contagion. Every successful strategy in controlling the SARS-CoV-2 infection depends on timely diagnosis, which should include testing of asymptomatic carriers. Consequently, increasing the throughput for clinical laboratories for the purposes of...

Interrelations between COVID-19 and other disorders.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7833539
Clinical Immunology (Orlando, Fla.); Gasmi A, Peana M et. al.

Dec 17th, 2020 - The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a respiratory tract virus that causes Coronavirus disease (COVID-19). The virus originated in Wuhan, China, in December 2019 and has spread across the globe to-date. The disease ranges from asymptomatic carriers to symptoms such as fever, sore throat, cough, lung infections, and in severe cases, acute respiratory distress syndr...

Asymptomatic patients as a source of transmission of COVID-19 in homeless shelters.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7834802
International Journal of Infectious Diseases : IJID : Off... Ralli M, Morrone A et. al.

Dec 15th, 2020 - Asymptomatic carriers account for over a third of all Coronavirus Disease 19 (COVID-19) cases and are characterized by the absence of symptoms but the same infectivity as symptomatic infections. The high percentage of asymptomatic COVID-19 patients is significant in settings with specific vulnerabilities, such as homeless shelters, where the consequences of an outbreak may be dramatic. In this ...

Sexual Health Implications of COVID-19 Pandemic.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7643626
Sexual Medicine Reviews; Pennanen-Iire C, Prereira-Lourenço M et. al.

Dec 14th, 2020 - A novel coronavirus (COVID-19) reached pandemic levels by March 11th, 2020, with a destructive impact across socioeconomic domains and all facets of global health, but little is known of its impact on sexual health. To review current knowledge on sexual health-related containment measures during pandemics, specifically COVID-19, and focus on 2 main areas: intimacy and relational dynamics and cl...

Epidemiological characterisation of asymptomatic carriers of COVID-19 in Colombia: a cr...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7722836
BMJ Open; Teherán AA, Camero Ramos G et. al.

Dec 9th, 2020 - Asymptomatic carriers (AC) of the new SARS-CoV-2 represent an important source of spread for COVID-19. Early diagnosis of these cases is a powerful tool to control the pandemic. Our objective was to characterise patients with AC status and identify associated sociodemographic factors. Using a cross-sectional design and the national database of daily occurrence of COVID-19, we characterised both...

Molecular epidemiology of SARS-CoV-2 clusters caused by asymptomatic cases in Anhui Pro...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7719853
BMC Infectious Diseases; Yuan Y, He J et. al.

Dec 8th, 2020 - COVID-19 is a newly emerging disease caused by a novel coronavirus (SARS-CoV-2), which spread globally in early 2020. Asymptomatic carriers of the virus contribute to the propagation of this disease, and the existence of asymptomatic infection has caused widespread fear and concern in the control of this pandemic. In this study, we investigated the origin and transmission route of SARS-CoV-2 in...

Angiotensin-Converting Enzyme 2 and COVID-19: Patients, Comorbidities, and Therapies.
https://doi.org/10.1152/ajplung.00259.2020
American Journal of Physiology. Lung Cellular and Molecul... Pathangey G, Fadadu PP et. al.

Nov 25th, 2020 - On March 11, 2020, the World Health Organization declared COVID-19 a pandemic, and the reality of the situation has finally caught up to the widespread reach of the disease. The presentation of the disease is highly variable, ranging from asymptomatic carriers to critical COVID-19. The availability of angiotensin-converting enzyme 2 (ACE2) receptors may reportedly increase the susceptibility an...

An overview on COVID-19 pandemic: from discovery to treatment.
https://doi.org/10.2174/1871526520666201109115820
Infectious Disorders Drug Targets; Panati K, Tatireddygari VRA et. al.

Nov 10th, 2020 - Recently, novel coronavirus infection (COVID-19) emerged in Wuhan, China has been declared as pandemic by WHO. Until now, no evidence is documented regarding its wild animal reservoir or intermediary host, but, human-to-human transmission, asymptomatic carriers were very much observed. The number of confirmed cases and death toll have been increased almost all over the world indicating its pote...

Type A Aortic Dissection During COVID-19 Pandemic: Report From Tertiary Aortic Centers ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7648657
Seminars in Thoracic and Cardiovascular Surgery; Fukuhara S, Tang H et. al.

Nov 10th, 2020 - Coronavirus disease 2019 (COVID-19) has substantially disrupted many processes of care related to emergency cardiac conditions, while there has been no clinical guidance regarding the management of type A aortic dissection. A retrospective multicenter study involving 52 consecutive patients (mean age 52.3, 28.9% women) with type A aortic dissection during COVID-19 pandemic was conducted at tert...

SARS-CoV-2 seroprevalence and transmission risk factors among high-risk close contacts:...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7831879
The Lancet. Infectious Diseases; Ng OT, Marimuthu K et. al.

Nov 5th, 2020 - The proportion of asymptomatic carriers and transmission risk factors of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) among household and non-household contacts remains unclear. In Singapore, extensive contact tracing by the Ministry of Health for every diagnosed COVID-19 case, and legally enforced quarantine and intensive health surveillance of close contacts provided a rare op...